DE69710921D1 - Heterocyclische substituierte pyrrolidinamid-derivate - Google Patents

Heterocyclische substituierte pyrrolidinamid-derivate

Info

Publication number
DE69710921D1
DE69710921D1 DE69710921T DE69710921T DE69710921D1 DE 69710921 D1 DE69710921 D1 DE 69710921D1 DE 69710921 T DE69710921 T DE 69710921T DE 69710921 T DE69710921 T DE 69710921T DE 69710921 D1 DE69710921 D1 DE 69710921D1
Authority
DE
Germany
Prior art keywords
pyrrolidinamide
derivatives
heterocyclic substituted
heterocyclic
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69710921T
Other languages
English (en)
Other versions
DE69710921T2 (de
Inventor
P Burkholder
D Maynard
M Kudlacz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69710921D1 publication Critical patent/DE69710921D1/de
Application granted granted Critical
Publication of DE69710921T2 publication Critical patent/DE69710921T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE69710921T 1996-12-19 1997-11-03 Heterocyclische substituierte pyrrolidinamid-derivate Expired - Lifetime DE69710921T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76981296A 1996-12-19 1996-12-19
PCT/US1997/019884 WO1998027086A1 (en) 1996-12-19 1997-11-03 Novel heterocyclic substituted pyrrolidine amide derivatives

Publications (2)

Publication Number Publication Date
DE69710921D1 true DE69710921D1 (de) 2002-04-11
DE69710921T2 DE69710921T2 (de) 2002-09-19

Family

ID=25086573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710921T Expired - Lifetime DE69710921T2 (de) 1996-12-19 1997-11-03 Heterocyclische substituierte pyrrolidinamid-derivate

Country Status (21)

Country Link
EP (1) EP0946548B1 (de)
JP (1) JP4195512B2 (de)
KR (1) KR100514263B1 (de)
CN (1) CN1119344C (de)
AR (1) AR009665A1 (de)
AT (1) ATE214063T1 (de)
AU (1) AU723966B2 (de)
BR (1) BR9714057A (de)
CA (1) CA2275527C (de)
DE (1) DE69710921T2 (de)
DK (1) DK0946548T3 (de)
ES (1) ES2169881T3 (de)
HK (1) HK1020947A1 (de)
HU (1) HUP0000315A3 (de)
IL (1) IL130223A (de)
NO (1) NO317760B1 (de)
NZ (1) NZ335975A (de)
PT (1) PT946548E (de)
TW (1) TW486477B (de)
WO (1) WO1998027086A1 (de)
ZA (1) ZA9711271B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
PL367944A1 (en) * 2001-07-20 2005-03-07 Pfizer Products Inc. Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
CN101861302A (zh) 2007-08-22 2010-10-13 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的吡咯烷芳基-醚
SG11202102440SA (en) 2018-10-29 2021-04-29 Boehringer Ingelheim Int Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
AU678023B2 (en) * 1993-05-06 1997-05-15 Aventis Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
EP0920425B1 (de) * 1995-11-17 2003-02-19 Aventis Pharmaceuticals Inc. Substituierte 4-(1h-benzimidazol-2-yl-amino)piperidine zur behandlung allergischer erkrankungen

Also Published As

Publication number Publication date
ES2169881T3 (es) 2002-07-16
NO993013L (no) 1999-08-18
IL130223A (en) 2005-09-25
EP0946548A1 (de) 1999-10-06
TW486477B (en) 2002-05-11
HUP0000315A2 (hu) 2001-04-28
CN1119344C (zh) 2003-08-27
PT946548E (pt) 2002-06-28
ZA9711271B (en) 1998-06-19
ATE214063T1 (de) 2002-03-15
HK1020947A1 (en) 2000-05-26
WO1998027086A1 (en) 1998-06-25
KR20000057668A (ko) 2000-09-25
DK0946548T3 (da) 2002-06-24
CA2275527A1 (en) 1998-06-25
KR100514263B1 (ko) 2005-09-15
CA2275527C (en) 2003-09-23
AU5160798A (en) 1998-07-15
JP4195512B2 (ja) 2008-12-10
JP2001506650A (ja) 2001-05-22
AU723966B2 (en) 2000-09-07
BR9714057A (pt) 2000-05-09
HUP0000315A3 (en) 2002-01-28
CN1241185A (zh) 2000-01-12
NZ335975A (en) 2000-11-24
EP0946548B1 (de) 2002-03-06
AR009665A1 (es) 2000-04-26
NO993013D0 (no) 1999-06-18
NO317760B1 (no) 2004-12-13
DE69710921T2 (de) 2002-09-19
IL130223A0 (en) 2000-06-01

Similar Documents

Publication Publication Date Title
ATE323682T1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
EE9900211A (et) Asendatud pürasooliderivaadid
BR9711262A (pt) Derivados 6,6 substituido hetero biciclicos
PT934320E (pt) Derivados de naftiridina
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO981946D0 (no) Imidazoquinazolin-derivater
DE69817186D1 (de) Diaminorhodamin-derivate
ATE255098T1 (de) Substituierte chromanderivate
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
BR9709065A (pt) Derivados de alquilaminobenzotiazole e-benzoxazol
ATE255099T1 (de) Substituierte chromanderivate
DE69841086D1 (de) 5-Deoxy-Cytidin-Derivate
FI955164A0 (fi) Heterosykliset johdannaiset
FI970110A0 (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
PT931087E (pt) Novos derivados de piranosido
DE69829682D1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin-derivate
NO992526D0 (no) Cephalosporin-derivater
PT906279E (pt) Derivados de pirrol
DE69828780D1 (de) Amidinocamptpthecin-derivate
NO981495D0 (no) Phenoxymetylpiperidin-derivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US